Top Markets
Coin of the day
Pacific Edge Limited Pacific Edge Limited

Pacific Edge Limited

PEB
Classificação em ações #18664
Based in Dunedin, New Zealand, Pacific Edge Limited, established in 2001,... Based in Dunedin, New Zealand, Pacific Edge Limited, established in 2001, operates as a cancer diagnostics firm. The company's core mission involves the research, development, and commercialization of advanced diagnostic and prognostic tools aimed at the early identification and ongoing management of various cancers. Its diagnostic solutions are accessible in New Zealand, the United States, Australia, and Singapore, with operations structured across Commercial and Research segments. A key offering is the Cxbladder suite, a collection of genomic urine tests specifically designed for detecting and managing bladder cancer. Within this suite, Cxbladder Resolve aids in identifying patients likely to present with more aggressive or advanced bladder cancer. Cxbladder Triage helps pinpoint individuals with haematuria who exhibit a low probability of bladder cancer, while Cxbladder Detect offers a non-invasive method for identifying bladder and other urinary tract cancers. Furthermore, Cxbladder Monitor facilitates continuous surveillance for disease recurrence in bladder cancer patients. Beyond its focus on bladder cancer, Pacific Edge is actively developing additional diagnostic innovations. These include Cxcolorectal, a prognostic gene signature for assessing outcomes in patients diagnosed with stage II or stage III colorectal cancers, alongside pipeline products targeting gastric, endometrial cancers, and melanoma.
Preço da ação
$0.15360289
Valor de mercado
$190.75M
Variação (1 dia)
6.25%
Variação (1 ano)
94.11%
País
NZ
Negociar Pacific Edge Limited (PEB)

Categoria

Histórico de preços das ações de Pacific Edge Limited (PEB)
Preço de fecho mais alto: $0.15 em 2026-08-01

Preço de fecho mais baixo: $0.12 em 2003-10-01
Histórico de preços das ações da Pacific Edge Limited de 2003 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) 37.68%
2025 36.21%
2024 24.01%
2023 -81.60%
2022 -65.88%
2021 23.95%
2020 768.10%
2019 -63.04%
2018 -7.32%
2017 -35.08%
2016 29.31%
2015 -53.04%
2014 -37.72%
2013 211.63%
2012 131.76%
2011 16.63%
2010 -14.96%
2009 177.05%
2008 -40.01%
2007 -2.18%
2006 -26.65%
2005 -29.42%
2004 82.34%
2003 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
$634.40 29.87%
US
$215.88 4.67%
US
$23.08 70.53%
CN
$337.43 103.63%
US
$155.35 31.32%
US